Skip to main navigation Skip to search Skip to main content

COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021

  • Anat Achiron*
  • , Mark Dolev
  • , Shay Menascu
  • , Daniela Noa Zohar
  • , Sapir Dreyer-Alster
  • , Shmuel Miron
  • , Emanuel Shirbint
  • , David Magalashvili
  • , Shlomo Flechter
  • , Uri Givon
  • , Diana Guber
  • , Yael Stern
  • , Michael Polliack
  • , Rina Falb
  • , Michael Gurevich
    • *Corresponding author for this work
  • Tel Aviv University

Research output: Contribution to journal › Article › peer-review

184 Scopus citations

Fingerprint

Dive into the research topics of 'COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Immunology and Microbiology